Effect of Controlled Ovarian Stimulation in Quality of Oocyte and Embryo
Launched by MINIA UNIVERSITY · Aug 31, 2020
Trial Information
Current as of May 04, 2025
Unknown status
Keywords
ClinConnect Summary
70 patients divided in to 2groups Group A controlled ovarian stimulation with H FSH and HHMg Group B controlled ovarian stimulation with HMG alone Results will be discussed later
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Infertil women aged from 20_35yr
- • 2. Normal utreus
- • 3. Normal ovaries
- • 4. unexplained infertility
- • 5. no endometriosis
- Exclusion Criteria:
- • 1 - poor responders to gonadotropin 2-Prior history of more than 3unsucceful ICSI 3-Any malformation of sexual organs
About Minia University
Minia University is a prestigious educational institution located in Egypt, dedicated to advancing medical research and clinical trials. With a commitment to fostering innovation and improving healthcare outcomes, the university collaborates with a diverse range of stakeholders, including healthcare professionals and researchers. Minia University aims to enhance clinical practices through rigorous research methodologies and ethical standards, contributing to the body of knowledge in the medical field while addressing local and global health challenges. The university's clinical trial initiatives are designed to evaluate new treatments and interventions, ensuring a positive impact on patient care and community health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Marwa Ba Tarahony
Principal Investigator
Faculty of Medicine, Minia University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials